Systematic review / meta-analysis / 2021
A meta-analysis found insufficient evidence to conclude whether vitamin E supplementation affects the risk or progression of Alzheimer's disease.
Researchers conducted a systematic review and meta-analysis of 5 cohort studies and 3 randomized controlled trials (total n = 14,262) to assess vitamin E supplementation and Alzheimer's disease (AD). The pooled relative risk for vitamin E supplementation and risk of AD was 0.81 (95% CI: 0.50-1.33, I² = 69.2%). Suitable data could not be extracted for a meta-analysis on AD progression due to a lack of unified standard outcome measures, and reliable evidence could not be obtained. The authors concluded that neither synthetic data on risk nor review of progression provided enough evidence to draw a specific conclusion.
Shows an association, not proof of cause and effect.
- Study type
- Systematic review and meta-analysis of cohort studies and RCTs
- Who was studied
- 14,262 participants from 5 cohort studies and 3 RCTs (1,313 AD risk cases, 244 progression cases)
- What was measured
- Risk of Alzheimer's disease (AD) and progression of AD
THE PAPER
Effects of vitamin E supplementation on the risk and progression of AD: a systematic review and meta-analysis.
Wang W, Li J, Zhang H, Wang X, Zhang X. Nutr Neurosci, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.